Cargando…

Next-of-Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part II: The Inspectors’ Perspective)

OBJECTIVE: The aim of the study was to explore regulatory inspectors’ experiences with a new method for next-of-kin involvement in investigation of adverse events causing patient death. A resilient healthcare perspective is used as the theoretical foundation. METHODS: The study design was a qualitat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiig, Siri, Schibevaag, Lene, Tvete Zachrisen, Rannveig, Hannisdal, Einar, Anderson, Janet E., Haraldseid-Driftland, Cecilie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612908/
https://www.ncbi.nlm.nih.gov/pubmed/31651541
http://dx.doi.org/10.1097/PTS.0000000000000634
_version_ 1784603537686134784
author Wiig, Siri
Schibevaag, Lene
Tvete Zachrisen, Rannveig
Hannisdal, Einar
Anderson, Janet E.
Haraldseid-Driftland, Cecilie
author_facet Wiig, Siri
Schibevaag, Lene
Tvete Zachrisen, Rannveig
Hannisdal, Einar
Anderson, Janet E.
Haraldseid-Driftland, Cecilie
author_sort Wiig, Siri
collection PubMed
description OBJECTIVE: The aim of the study was to explore regulatory inspectors’ experiences with a new method for next-of-kin involvement in investigation of adverse events causing patient death. A resilient healthcare perspective is used as the theoretical foundation. METHODS: The study design was a qualitative process evaluation of the new involvement method in 2 Norwegian counties. Next of kin, who had lost a close family member in an adverse event, were invited to a 2-hour face-to-face meeting with the inspectors. Data collection involved 3 focus group interviews with regulatory inspectors and observation (20 hours) of the meetings (2017–2018). Data were analyzed by a thematic content analysis. RESULTS: Next-of-kin involvement informed the investigations by additional and new information about the adverse events and by different versions of the investigators’ earlier obtained information, such as time sequences, what happened and how, and who were involved. Inspectors considered next of kin as a key source of information that contributed to improve the quality of the investigation. The downside was that the involvement method increased work load and could challenge the principle of equal treatment in regulatory practice. CONCLUSIONS: Involvement of next of kin in regulatory investigation of adverse events causing patient death contributes to a better understanding of work as done in clinical practice and contributes to strengthen the learning potential in resilience.
format Online
Article
Text
id pubmed-8612908
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-86129082021-11-29 Next-of-Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part II: The Inspectors’ Perspective) Wiig, Siri Schibevaag, Lene Tvete Zachrisen, Rannveig Hannisdal, Einar Anderson, Janet E. Haraldseid-Driftland, Cecilie J Patient Saf Original Studies OBJECTIVE: The aim of the study was to explore regulatory inspectors’ experiences with a new method for next-of-kin involvement in investigation of adverse events causing patient death. A resilient healthcare perspective is used as the theoretical foundation. METHODS: The study design was a qualitative process evaluation of the new involvement method in 2 Norwegian counties. Next of kin, who had lost a close family member in an adverse event, were invited to a 2-hour face-to-face meeting with the inspectors. Data collection involved 3 focus group interviews with regulatory inspectors and observation (20 hours) of the meetings (2017–2018). Data were analyzed by a thematic content analysis. RESULTS: Next-of-kin involvement informed the investigations by additional and new information about the adverse events and by different versions of the investigators’ earlier obtained information, such as time sequences, what happened and how, and who were involved. Inspectors considered next of kin as a key source of information that contributed to improve the quality of the investigation. The downside was that the involvement method increased work load and could challenge the principle of equal treatment in regulatory practice. CONCLUSIONS: Involvement of next of kin in regulatory investigation of adverse events causing patient death contributes to a better understanding of work as done in clinical practice and contributes to strengthen the learning potential in resilience. Lippincott Williams & Wilkins 2021-12 2019-10-24 /pmc/articles/PMC8612908/ /pubmed/31651541 http://dx.doi.org/10.1097/PTS.0000000000000634 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Studies
Wiig, Siri
Schibevaag, Lene
Tvete Zachrisen, Rannveig
Hannisdal, Einar
Anderson, Janet E.
Haraldseid-Driftland, Cecilie
Next-of-Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part II: The Inspectors’ Perspective)
title Next-of-Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part II: The Inspectors’ Perspective)
title_full Next-of-Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part II: The Inspectors’ Perspective)
title_fullStr Next-of-Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part II: The Inspectors’ Perspective)
title_full_unstemmed Next-of-Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part II: The Inspectors’ Perspective)
title_short Next-of-Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part II: The Inspectors’ Perspective)
title_sort next-of-kin involvement in regulatory investigations of adverse events that caused patient death: a process evaluation (part ii: the inspectors’ perspective)
topic Original Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612908/
https://www.ncbi.nlm.nih.gov/pubmed/31651541
http://dx.doi.org/10.1097/PTS.0000000000000634
work_keys_str_mv AT wiigsiri nextofkininvolvementinregulatoryinvestigationsofadverseeventsthatcausedpatientdeathaprocessevaluationpartiitheinspectorsperspective
AT schibevaaglene nextofkininvolvementinregulatoryinvestigationsofadverseeventsthatcausedpatientdeathaprocessevaluationpartiitheinspectorsperspective
AT tvetezachrisenrannveig nextofkininvolvementinregulatoryinvestigationsofadverseeventsthatcausedpatientdeathaprocessevaluationpartiitheinspectorsperspective
AT hannisdaleinar nextofkininvolvementinregulatoryinvestigationsofadverseeventsthatcausedpatientdeathaprocessevaluationpartiitheinspectorsperspective
AT andersonjanete nextofkininvolvementinregulatoryinvestigationsofadverseeventsthatcausedpatientdeathaprocessevaluationpartiitheinspectorsperspective
AT haraldseiddriftlandcecilie nextofkininvolvementinregulatoryinvestigationsofadverseeventsthatcausedpatientdeathaprocessevaluationpartiitheinspectorsperspective